Boehringer, Lilly won't sell diabetes pill in Germany
FRANKFURT, Sept 2 (Reuters) - Drugmakers Boehringer-Ingelheim and Eli Lilly have called off plans to market their Type 2 diabetes drug linagliptin in Germany because new legislation in the country could mean that pill's price could end up being too low.
Boehringer, Lilly won't sell diabetes pill in Germany | Reuters
FRANKFURT, Sept 2 (Reuters) - Drugmakers Boehringer-Ingelheim and Eli Lilly have called off plans to market their Type 2 diabetes drug linagliptin in .Read More
Boehringer-Lilly won't launch Trajenta in Germany | InPharm
Boehringer Ingelheim and Lilly have decided not to launch their new diabetes drug Trajenta in Germany ... Boehringer-Lilly won't launch Trajenta in Germany.Read More
FDA OKs New Diabetes Pill From Boehringer, Lilly - ABC News
FDA OKs New Diabetes Pill From Boehringer, Lilly ... is headquartered in Germany, with U.S. offices in Danbury, Conn. Eli Lilly ... 13 Things Experts Won't .Read More
FDA OKs new diabetes pill from Boehringer, Lilly | Pharmaceutical ...
New diabetes pill from Boehringer, Lilly enters US ... Boehringer is headquartered in Germany, with U.S. offices in Danbury, Conn. Eli Lilly & Co. Inc. is ... profession) won’t .Read More
Boehringer-Lilly's Trajenta wins European approval | InPharm
Boehringer Ingelheim and Eli Lilly’s new type II diabetes drug Trajenta has been ... Boehringer-Lilly won't launch Trajenta in Germany; Boehringer-Lilly launch diabetes drug .Read More
Boehringer, Lilly Won’t Introduce Trajenta in Germany on Pricing ...
Boehringer, Lilly Won’t Introduce Trajenta in Germany ... Boehringer Ingelheim GmbH and partner Eli Lilly & Co. have decided not to make the new diabetes ... Sale.Read More
Lilly and Boehringer Ingelheim in Diabetes Alliance - NYTimes.com
company Eli Lilly will pay $387 million to a German drug maker, Boehringer Ingelheim ... linagliptin, a daily pill for Type 2 diabetes ... but it probably won't work .Read More
Lilly-Boehringer diabetes pill recommended for EU approval ...
FDA OKs new diabetes pill from Lilly, Boehringer; Lilly teams with ... Germany-based Boehringer agreed in January to develop and sell jointly, sharing equally in costs .Read More
UPDATE 2-Eli Lilly in 5-drug diabetes pact with Boehringer | Reuters
Eli Lilly (LLY.N) struck a drug-development alliance with Germany's Boehringer Ingelheim ... two of Boehringer's experimental diabetes pills ... Zyprexa drug sale .Read More
Lilly, Boehringer collaborate on diabetes drugs - BusinessWeek
Eli Lilly and Co. will pay Boehringer Ingelheim $387.4 million and work with the German drugmaker in a diabetes drug ... Any Luck, You Won't ... Now, How to Sell It?.Read More
Lilly's New Diabetes Drug Now Available - Newsroom - Inside ...
Pacers Continue Ticket Sale ... Lilly's New Diabetes Drug Now Available. InsideINdianaBusiness.com Report.Read More
Lilly, Boehringer diabetes drug gets European OK - Yahoo! Finance
Lilly, Boehringer diabetes drug gets European OK Lilly, Boehringer diabetes drug ... earlier this year to develop and sell ... Germany; Hong Kong; India; Italy; Japan; Korea .Read More
Lilly, Boehringer diabetes drug gets European OK - BusinessWeek
With Any Luck, You Won't Win the Lottery; Billy ... Lilly, Boehringer diabetes drug gets European OK ... agreement earlier this year to develop and sell .Read More
Boehringer's First Diabetes Pill May Be Challenge to Merck ...
Boehringer Ingelheim GmbH ’s first diabetes pill ... sell the once-daily pill, said Maximilian von Eynatten, medical affairs adviser to the Ingelheim, Germany .Read More
Lilly, BI to partner on diabetes drugs - PRWeek US
Eli Lilly announced a new diabetes drug partnership with Boehringer Ingelheim at the JP Morgan ... Edelman holding company won't copy ... PR Report (Germany) Campaign (Asia .Read More
